CANCER CHEMOTHERAPY AND PHARMACOLOGY, cilt.73, sa.6, ss.1163-1171, 2014 (SCI-Expanded)
Serum LDH, CEA, and CA19-9 levels are important tumor markers in pancreatic cancer. The purpose of this study was to evaluate the clinical significance of serum LDH, CEA, and CA19-9 levels in metastatic pancreatic cancer (MPC) receiving gemcitabine-based chemotherapy.